• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude+Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

MannKind Corporation - Common Stock (NQ:MNKD)

3.520 -0.030 (-0.85%)
Streaming Delayed Price Updated: 4:00 PM EDT, May 8, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 9,544,170
Open 3.560
Bid (Size) 3.570 (700)
Ask (Size) 3.600 (1,500)
Prev. Close 3.550
Today's Range 3.400 - 3.680
52wk Range 2.230 - 6.510
Shares Outstanding 264,305,532
Dividend Yield N/A
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
MannKind (MNKD) Q1 2026 Earnings Transcript ↗
May 06, 2026
MannKind (MNKD) Q1 2026 Earnings Transcript 
Via The Motley Fool
MannKind Corp (NASDAQ:MNKD) Q1 2026 Revenue Miss and Wider EPS Loss Overshadow Strong Pipeline Progress ↗
May 06, 2026
Via Chartmill

Performance

YTD
-37.1%
-37.1%
1 Month
+34.9%
+34.9%
3 Month
-39.2%
-39.2%
6 Month
-37.5%
-37.5%
1 Year
-24.0%
-24.0%

More News

Read More
News headline image
MannKind Reports First Quarter 2026 Financial Results and Provides Business Update
May 06, 2026
From MannKind
Via GlobeNewswire
Keep an eye on the top gainers and losers in Wednesday's session. ↗
May 06, 2026
Via Chartmill
MannKind Corp (NASDAQ:MNKD) Reports Q4 2025 Revenue Beat and Strategic Outlook for 2026 ↗
February 26, 2026
Via Chartmill
MannKind Rallies On Optimism Of Two Imminent Product Launches: Analyst Sees ‘Multiple Headwinds’ For Stock In 2026 ↗
January 08, 2026
Via Stocktwits
Wednesday's session: gap up and gap down stocks ↗
May 06, 2026
Via Chartmill
News headline image
MannKind Announces Ralinepag Dry Powder Inhalation (DPI) Program to be Pursued for Pulmonary Hypertension and Fibrotic Lung Diseases
May 06, 2026
From MannKind
Via GlobeNewswire
News headline image
MannKind to Report First Quarter 2026 Financial Results on May 6, 2026
April 29, 2026
From MannKind
Via GlobeNewswire
News headline image
MannKind to Present New Data From Pediatric and Adult Studies of Afrezza® at ATTD 2026
March 09, 2026
From MannKind
Via GlobeNewswire
News headline image
MannKind Announces Settlement of Convertible Senior Notes
March 05, 2026
From MannKind
Via GlobeNewswire
News headline image
MannKind to Participate in Upcoming Investor Conferences
March 04, 2026
From MannKind
Via GlobeNewswire
News headline image
What's Going On With MannKind Stock Friday? ↗
February 27, 2026
Via Benzinga
News headline image
Why MannKind Stock Tumbled on Thursday ↗
February 26, 2026
Via The Motley Fool
News headline image
MannKind Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
February 26, 2026
From MannKind
Via GlobeNewswire
Let's take a look at the stocks that are in motion in today's session. ↗
February 25, 2026
Via Chartmill
News headline image
MannKind Stock Plummets After Partner United Therapeutics Unveils New ‘Category Killer Product’ ↗
February 25, 2026
Via Stocktwits
Here are the top movers in Wednesday's session. ↗
February 25, 2026
Via Chartmill
The market is filled with gapping stocks in Wednesday's session. ↗
February 25, 2026
Via Chartmill
News headline image
MannKind to Participate in the Oppenheimer 36th Annual Healthcare Life Sciences Conference
February 19, 2026
From MannKind
Via GlobeNewswire
News headline image
MannKind to Report Fourth Quarter and Full Year 2025 Financial Results on February 26, 2026
February 18, 2026
From MannKind
Via GlobeNewswire
News headline image
MannKind Announces First Patient Enrolled in INHALE-1ST Pediatric Study Evaluating Afrezza® for Youth with Newly-Diagnosed Type 1 Diabetes (T1D)
February 09, 2026
From MannKind
Via GlobeNewswire
News headline image
Why Did MNKD Stock Jump Over 7% In Pre-Market Today? ↗
January 26, 2026
Via Stocktwits
News headline image
MannKind Announces FDA Approval of Updated Afrezza® Label Providing Starting Dose Guidance when Switching from Multiple Daily Injections (MDI) or Insulin Pump Mealtime Therapy
January 26, 2026
From MannKind
Via GlobeNewswire
News headline image
Breaking Barriers: How 2026’s Top Clinical Leaders Are Disrupting Chronic Disease Markets
January 23, 2026
From Equity Insider
Via GlobeNewswire

Frequently Asked Questions

Is MannKind Corporation - Common Stock publicly traded?
Yes, MannKind Corporation - Common Stock is publicly traded.
What exchange does MannKind Corporation - Common Stock trade on?
MannKind Corporation - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for MannKind Corporation - Common Stock?
The ticker symbol for MannKind Corporation - Common Stock is MNKD on the Nasdaq Stock Market
What is the current price of MannKind Corporation - Common Stock?
The current price of MannKind Corporation - Common Stock is 3.520
When was MannKind Corporation - Common Stock last traded?
The last trade of MannKind Corporation - Common Stock was at 05/08/26 04:00 PM ET
What is the market capitalization of MannKind Corporation - Common Stock?
The market capitalization of MannKind Corporation - Common Stock is 930.36M
How many shares of MannKind Corporation - Common Stock are outstanding?
MannKind Corporation - Common Stock has 930M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap